These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 14631004)
1. Public health. AIDS vaccine still alive as booster after second failure in Thailand. Cohen J Science; 2003 Nov; 302(5649):1309-10. PubMed ID: 14631004 [No Abstract] [Full Text] [Related]
2. AIDS research. Debate begins over new vaccine trials. Cohen J Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856 [No Abstract] [Full Text] [Related]
3. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576 [No Abstract] [Full Text] [Related]
8. AIDS vaccines: back to 'plan A'. Check E Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164 [No Abstract] [Full Text] [Related]
9. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Emini EA; Koff WC Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131 [No Abstract] [Full Text] [Related]
10. First AIDS vaccine trial launched. Science; 1998 Jun; 280(5370):1697. PubMed ID: 9660708 [No Abstract] [Full Text] [Related]
11. Uganda may host AIDS vaccine trial. Holden C Science; 1996 May; 272(5262):657. PubMed ID: 8614821 [No Abstract] [Full Text] [Related]
12. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines. Robinson HL; Weinhold KJ J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331 [No Abstract] [Full Text] [Related]
13. Prime-boost immunization strategies against HIV. Barnett SW; Klinger JM; Doe B; Walker CM; Hansen L; Duliège AM; Sinangil FM AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S299-309. PubMed ID: 9814958 [No Abstract] [Full Text] [Related]
14. Hope in a vial. Will there be an AIDS vaccine anytime soon? Ezzell C Sci Am; 2002 Jun; 286(6):38-45. PubMed ID: 12030090 [No Abstract] [Full Text] [Related]
15. AIDS research. Novel antibody response may explain HIV vaccine success. Cohen J Science; 2011 Sep; 333(6049):1560. PubMed ID: 21921167 [No Abstract] [Full Text] [Related]
16. RV144: old vs. new. Weiner DB Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335 [No Abstract] [Full Text] [Related]
17. AIDS vaccines: on the trail of two trials. Moore JP Nature; 2002 Jan; 415(6870):365-6. PubMed ID: 11807523 [No Abstract] [Full Text] [Related]
18. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Karnasuta C; Paris RM; Cox JH; Nitayaphan S; Pitisuttithum P; Thongcharoen P; Brown AE; Gurunathan S; Tartaglia J; Heyward WL; McNeil JG; Birx DL; de Souza MS; Vaccine; 2005 Mar; 23(19):2522-9. PubMed ID: 15752839 [TBL] [Abstract][Full Text] [Related]
19. Steering a course to an AIDS vaccine. Baltimore D Science; 2002 Jun; 296(5577):2297. PubMed ID: 12089410 [No Abstract] [Full Text] [Related]